Issue · Criminal Justice

Criminal Justice (Drug Policy)

Every criminal justice bill, vote, and legislator stance in Washington, automatically classified by Maddy, our AI policy reader.

Total bills
14
2025-2026 Regular Session
Top supporter
Adrian Cortes
100% support rate
Top opponent
Bob Hasegawa
33% support rate
Ranked legislators
10
5 support · 5 oppose
Key legislators

Who's moving drug policy in Washington

Legislators moving drug policy in Washington
Legislator Party Stance Support rate Votes
Adrian Cortes
Adrian Cortes Senate · District 18
D
Strong +
100% 5
Julio Cortes
Julio Cortes House · District 38
D
Strong +
100% 5
Annette Cleveland
Annette Cleveland Senate · District 49
D
Strong +
100% 3
Curtis King
Curtis King Senate · District 14
R
Strong +
100% 3
Deb Krishnadasan
Deb Krishnadasan Senate · District 26
D
Strong +
100% 3
Bob Hasegawa
Bob Hasegawa Senate · District 11
D
Oppose
33% 3
Claire Wilson
Claire Wilson Senate · District 30
D
Oppose
33% 3
Claudia Kauffman
Claudia Kauffman Senate · District 47
D
Oppose
33% 3
Noel Frame
Noel Frame Senate · District 36
D
Oppose
33% 3
RS
Rebecca Saldaña Senate · District 37
D
Oppose
33% 3
Showing 1–10 of 14 bills

All criminal justice bills

in committee · Washington · House Feb 5, 2026

HB 2731: Prohibiting local jurisdictions from banning cannabis production, processing, and sales.

HB 2731 prohibits local governments in Washington from banning cannabis businesses by banning ordinances, regulations, or land use plans that would prevent licensed producers, processors, or retailers from operating in their jurisdictions. The bill also expands the state's social equity program for cannabis licenses, requiring that at least 51% of ownership in new licenses meets specific criteria (e.g., living in a historically impacted area, having a cannabis-related arrest, or meeting income thresholds). It sets aside additional licenses for social equity applicants and mandates a scoring system to prioritize them. This law directly affects local governments (by removing their ban authority), cannabis businesses (by expanding operational areas), and social equity applicants (by creating priority access to new licenses).
Sub-Topics Drug Policy
in committee · Washington · Senate Feb 26, 2026

SB 6204: Legalizing the home cultivation of cannabis by persons who are 21 years of age and older.

SB 6204 legalizes home cannabis cultivation for Washington residents aged 21 and older, allowing up to six plants per household (with a maximum of 15 plants total for a single residence). It sets specific limits on cannabis products, including 0.5 ounces of useable cannabis, 36 ounces of liquid-infused products, or 100 milligrams of THC per 24-hour period for noncommercial sharing. The bill prohibits visible cultivation from public view or neighboring properties and maintains criminal penalties for exceeding these limits or for possession by those under 21. It explicitly excludes medical cannabis patients (covered under separate law) and clarifies that commercial cannabis regulations remain unaffected.
Sub-Topics Drug Policy
in committee · Washington · House Jan 22, 2026

HB 2614: Legalizing the home cultivation of cannabis by persons who are 21 years of age and older.

HB 2614 legalizes home cultivation of cannabis for Washington residents aged 21 or older, permitting up to six plants per person on their premises with a maximum of 15 plants total per housing unit. It sets specific possession limits (e.g., no more than half an ounce of useable cannabis) and requires cultivation to remain non-visible from public view to avoid penalties. Violations like exceeding plant limits or visible cultivation would result in civil penalties, not criminal charges. The bill does not affect medical cannabis programs or commercial cannabis businesses.
Sub-Topics Drug Policy
in committee · Washington · Senate Jan 14, 2026

SB 6145: Concerning the possession of contraband at any correctional facility or institution by an employee.

SB 6145 requires immediate suspension and termination of state and contractor employees at correctional facilities who possess contraband (such as weapons, drugs, or security-threatening items) on facility premises. Employees found guilty of contraband possession through evidence-based review or related criminal convictions must be terminated, and contractors must remove such employees from facility-access roles. Contractors must also demonstrate improved hiring, training, and monitoring practices to renew contracts, with the department requiring proof of progress before approval. The bill allows public disclosure of terminated employees or contracts, protecting officials from liability for releasing relevant information.
in committee · Washington · House Jan 12, 2026

HB 1229: Resentencing of individuals sentenced as a persistent offender.

HB 1229 allows individuals sentenced as persistent offenders or receiving exceptional sentences (to avoid persistent offender status) due to a second-degree robbery conviction to seek resentencing. It requires public defense offices to review cases where second-degree robbery was used to establish persistent offender status or as part of a plea agreement, and to file motions for resentencing if eligible. The bill mandates courts to resentence these individuals as if second-degree robbery was not the "most serious offense" at sentencing, effectively removing it from consideration in sentencing calculations. This policy change applies to both current sentences and future cases after July 2021, ensuring second-degree robbery no longer qualifies as a "most serious offense" for persistent offender sentencing.
in committee · Washington · House Jan 12, 2026

HB 2072: Sustaining and expanding behavioral health services by levying an opioid impact fee on opioid manufacturers.

HB 2072 imposes a fee of $0.01 per morphine milligram equivalent on opioid manufacturers for prescription opioids dispensed in Washington. The fee funds a new "prescription opioid impact account," with 50% dedicated to behavioral health programs for children, youth, and young adults. Funds also reimburse the state for modifying the prescription monitoring program and cover administrative costs (capped at 12% annually). Manufacturers must report quarterly opioid dispensing data to the Department of Health and pay the fee within 45 days, with penalties for late payment.
passed · Washington · Senate Feb 26, 2026

SB 5758: Supporting social equity in the cannabis industry by establishing distance requirements for certain licensees.

Senate Bill 5758 (SB 5758) aims to support social equity within Washington's cannabis industry. It proposes to achieve this by establishing specific distance requirements for certain licensed cannabis businesses. The bill amends RCW 69.50.331, which broadly outlines the licensing process, including application evaluation, license suspension, and qualifications for producers, processors, and retailers. While the provided text details general licensing procedures, it does not specify the new distance requirements themselves.
Sub-Topics Drug Policy
in committee · Washington · House Jan 12, 2026

HB 1197: Making 2023-2025 fiscal biennium second supplemental operating appropriations.

HB 1197 is a supplemental appropriations bill funding state court operations and specific programs for the 2023-2025 fiscal biennium. It allocates funds primarily to state courts (e.g., $28.6 million for the Court of Appeals in FY 2025) and counties for juvenile justice services ($7 million annually for truancy and youth case management), court security in rural areas ($1 million), and an equity dashboard program ($1.35 million for data collection on justice disparities). The bill directs specific funding streams for court-appointed attorneys, lactation spaces in courthouses, and opioid settlement fund uses. These appropriations directly affect state courts, county juvenile programs, and local court facilities across Washington.
in committee · Washington · Senate Jan 12, 2026

SB 5782: Concerning impaired driving.

Washington's SB 5782 updates impaired driving laws by establishing a 0.08% blood alcohol concentration (BAC) limit and a 5.00 ng/mL THC concentration limit for DUI charges. It creates new affirmative defenses allowing defendants to prove they consumed alcohol or cannabis *after* driving but *before* testing, but requires them to notify prosecutors early in the case. The bill also clarifies that blood/breath tests taken over two hours after driving can still be used as evidence for impairment. Repeat offenses involving prior DUI convictions or vehicular crimes become class B felonies, while first offenses remain gross misdemeanors. This directly affects drivers in Washington facing DUI charges, particularly those using cannabis.
Sub-Topics Drug Policy
passed · Washington · Senate Mar 12, 2026

SB 5071: Updating the endangerment with a controlled substance statute.

Senate Bill 5071 updates Washington's law regarding endangerment with a controlled substance. It expands the types of substances covered to include fentanyl or synthetic opioids, in addition to methamphetamine, when a person knowingly or recklessly exposes a child or dependent adult to them. The bill also changes the required mental state for the crime from "knowingly or intentionally" to "knowingly or recklessly." It specifically exempts legitimate medical administration of these substances and protects Department of Children, Youth, and Families personnel acting within their role from criminal liability under this statute. The crime remains classified as a Class B felony.
Sub-Topics Drug Policy
Showing 1 to 10 of 14 bills
1 2 Next